Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2026-03-01 @ 3:54 PM
Study NCT ID:
NCT04059406
Status:
TERMINATED
Last Update Posted:
2025-02-18
First Post:
2019-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx)
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-14
First Submit QC Date:
None
Study First Post Date:
2019-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-11
Results First Submit QC Date:
None
Results First Post Date:
2025-02-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-02-18
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-14
Last Update Post Date:
2025-02-18
Last Update Post Date Type:
ACTUAL